病態・病理学講座

Keyphrases

1. Platelet-derived Growth Factor Receptor (PDGFR) 100%
2. Platelet-derived Growth factor-BB (PDGF-BB) 67%
3. Pericytes 48%
4. Macrophages 44%
5. Sepsis 43%
6. Insulin Resistance 37%
7. KO Mice 35%
8. Follicular Lymphoma 35%
9. IgG4-related Disease (IgG4-RD) 29%
10. Glucose Metabolism 26%
11. TFIIE 25%
12. Gastrointestinal Follicular Lymphoma 24%
13. Small Interfering RNA (siRNA) 23%
14. Mouse Model 23%
15. Cecal Puncture 22%
16. Cecal Ligation 22%
17. CD206 22%
18. Guinea pig 22%
19. Tumor 21%
20. M2-like 21%
21. Adipose Tissue 20%
22. Apoptosis 19%
23. Vascular Endothelial Growth Factor 19%
24. Nuclear factor-B 19%
25. Angiogenesis 18%
26. Lung 18%
27. General Transcription Factor 17%
28. Transforming Growth Factor-β 17%
29. Transcription Factor 17%
30. Preadipocytes 16%
31. Adipose Tissue Expansion 16%
32. Transient Middle Cerebral Artery Occlusion (tMCAO) 16%
33. Diet-induced Obese Mice 15%
34. Oligodendrocyte Precursor Cells 15%
35. Obesity 15%
36. White Adipose Tissue 14%
37. Glucocorticoid Receptor Expression 14%
38. Salivary Duct Carcinoma 14%
39. Neutrophils 14%
40. Extracellular Vesicles 14%
41. Vascular Remodeling 14%
42. Adipose Tissue Inflammation 14%
43. Neural Stem Cells 14%
44. Platelet-derived Growth Factor Receptor β 14%
45. Focal Cerebral Ischemia 14%
46. Fas-associated Death Domain 14%
47. Diet-induced Obesity 14%
48. SIRT1 Activator 14%
49. Angiogenic 14%
50. Kawasaki Disease 14%
51. NF-B 14%
52. Glioma 13%
53. Fibroblasts 13%
54. Lymph Node 13%
55. Diffuse Large B-cell Lymphoma (DLBCL) 12%
56. Ocular Adnexal 12%
57. Therapeutic Target 12%
58. Gene-deficient Mice 12%
59. Nestin 11%
60. Central Nervous System 11%
61. High Glucose 11%
62. Tumor Growth 11%
63. Epstein-Barr Virus 11%
64. Duodenum 11%
65. Adipocyte 11%
66. Death Receptor 11%
67. Vascular Endothelial Growth Factor Receptor (VEGFR) 11%
68. Moyamoya Disease 11%
69. Adipocyte Progenitors 11%
70. Natural Killer T-cell Lymphoma 11%
71. Clinicopathological Analysis 11%
72. Receptor Gene 11%
73. Inflammation 11%
74. Phosphorylation 10%
75. Cell Apoptosis 10%
76. Decoy Oligodeoxynucleotide 10%
77. Oligodendroglial 10%
78. Growth Factor Signaling 10%
79. Signaling Pathway 9%
80. Transcription Initiation 9%
81. Eosinophils 9%
82. Interleukin-1β 9%
83. Blood-brain Barrier 9%
84. RNA Polymerase II (RNAPII) 9%
85. MALT Lymphoma 9%
86. Vascular Smooth muscle Cells 9%
87. Combined Modality Therapy 9%
88. Skin Fibroblasts 9%
89. Helicobacter Pylori Eradication 9%
90. Flox 9%
91. High-fat Diet 9%
92. Apoptotic Pathway 9%
93. Insulin 9%
94. Myeloid Cells 9%
95. Malignant Transformation 8%
96. Anti-apoptosis 8%
97. Biopsy Specimen 8%
98. Trichohyalin 8%
99. Induced Endothelial Cells 8%
100. Homeostatic Control 8%

Medicine and Dentistry

1. Follicular Lymphoma 87%
2. Neoplasm 64%
3. Diffuse Large B-Cell Lymphoma 60%
4. B Cell 36%
5. NK T Cell Lymphoma 34%
6. Programmed Cell Death 33%
7. Platelet Derived Growth Factor Receptor 32%
8. Immunoglobulin G4 30%
9. IgG4-Related Disease 30%
10. Germinal Center 30%
11. Diseases 28%
12. MALT Lymphoma 26%
13. Peripheral T-Cell Lymphoma 23%
14. T-Cell Lymphoma 23%
15. Diet Induced Obesity 22%
16. Epstein Barr Virus 21%
17. Endothelial Cell 21%
18. Pericyte 20%
19. Disease Course 20%
20. Adenocarcinoma 19%
21. Sepsis 19%
22. Small Interfering RNA 18%
23. Lymph Node 18%
24. Insulin Resistance 17%
25. Lymphoma Cell 17%
26. Death Receptor 16%
27. Duodenum 15%
28. Lymphoproliferative Disease 15%
29. Biopsy Technique 15%
30. Salivary Duct Carcinoma 14%
31. Death Domain 14%
32. Glucose Metabolism 14%
33. B-Cell Lymphoma 14%
34. Lymphadenopathy 14%
35. Cytotoxic T-Cell 14%
36. Platelet Derived Growth Factor 13%
37. T Lymphocyte Receptor 13%
38. Gastrointestinal Tract 12%
39. Classical Hodgkin Lymphoma 12%
40. Downregulation 12%
41. Neck 12%
42. Malignant Neoplasm 11%
43. Nuclear Factor 11%
44. Alternative Complement Pathway C3 C5 Convertase 11%
45. Polyp 11%
46. Non-Hodgkin Lymphoma 11%
47. Upregulation 11%
48. Immune Checkpoint Inhibitor 11%
49. Large-Cell Lymphoma 11%
50. Bleeding 10%
51. T-Cell Gene Rearrangement 10%
52. Follicular Dendritic Cells 10%
53. Tumor Cell 10%
54. Vascularity 9%
55. CD8 Antigen 9%
56. Malignant Transformation 9%
57. Salivary Gland 9%
58. Immunoglobulin Producing Cell 9%
59. Helicobacter Pylori 9%
60. Immunohistochemistry 9%
61. T Cell 9%
62. Cancer Growth Factor 8%
63. Colon 8%
64. Progenitor Cell 8%
65. Prognostic Factor 8%
66. Angiofollicular Lymph Node Hyperplasia 8%
67. Clinical Stage 8%
68. microRNA 8%
69. Soluble Interleukin 2 Receptor 8%
70. Cecal Ligation and Puncture-Induced Sepsis 8%
71. Endoscopy 8%
72. Intestine Injury 8%
73. Diagnosis 8%
74. CD3 Antigen 8%
75. Palate 8%
76. Lymph Duct 8%
77. Laparoscopic Surgery 8%
78. Gene Expression Profiling 8%
79. Connective Tissue 8%
80. Metastatic Carcinoma 8%
81. Stomach Disease 7%
82. Fibroblast 7%
83. Disease 7%
84. Lung 7%
85. Morphology 7%
86. Adipose Tissue 7%
87. Impaired Glucose Tolerance 7%
88. Immune-Related Adverse Events 7%
89. Tissue Expansion 7%
90. Anaplastic Lymphoma Kinase 7%
91. Anaplastic Large Cell Lymphoma 7%
92. Myeloid Tissue 7%
93. Vascular Remodeling 7%
94. Oligodeoxynucleotide 7%
95. Bile Duct Injury 7%
96. Sarcomatoid 7%
97. Orphan Receptor 7%
98. Intrahepatic Bile Duct 7%
99. Cystic Hygroma 7%
100. Ganglioneuroblastoma 7%